Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,738
datasets available to search
ShareScore release 0.9.0
Dataset results
2,738 results for “multiple sclerosis”
A TSEC for Symptom Management in Menopausal Women With Multiple Sclerosis
ClinicalTrials.gov study NCT02710214. IPD Sharing: Not stated. Countries: 1. Publications: 10.
Stem Cell Therapy for Patients With Multiple Sclerosis Failing Alternate Approved Therapy- A Randomized Study
ClinicalTrials.gov study NCT00273364. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple Sclerosis
ClinicalTrials.gov study NCT01216072. IPD Sharing: Not stated. Countries: 3. Publications: 4.
An Extension Study of the Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing Multiple Sclerosis
ClinicalTrials.gov study NCT00670449. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Safety and Efficacy Study of Daclizumab High Yield Process (DAC HYP) to Treat Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00390221. IPD Sharing: Not stated. Countries: 8. Publications: 2.
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
ClinicalTrials.gov study NCT04035005. IPD Sharing: YES. Countries: 23. Publications: 0.
Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis
ClinicalTrials.gov study NCT00110396. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis (RRMS)
ClinicalTrials.gov study NCT05123703. IPD Sharing: YES. Countries: 25. Publications: 1.
Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis
ClinicalTrials.gov study NCT01328379. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019
ClinicalTrials.gov study NCT01797965. IPD Sharing: Not stated. Countries: 27. Publications: 1.
Study to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS)
ClinicalTrials.gov study NCT03277248. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Oral Cladribine in Early Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT00725985. IPD Sharing: Not stated. Countries: 34. Publications: 5.
Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00220779. IPD Sharing: Not stated. Countries: 12. Publications: 1.
Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis
ClinicalTrials.gov study NCT00906399. IPD Sharing: Not stated. Countries: 26. Publications: 11.
Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00803049. IPD Sharing: Not stated. Countries: 21. Publications: 4.
Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00078338. IPD Sharing: Not stated. Countries: 12. Publications: 1.
Digital Cognition in Multiple Sclerosis
ClinicalTrials.gov study NCT03569618. IPD Sharing: NO. Countries: 1. Publications: 3.
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
ClinicalTrials.gov study NCT01412333. IPD Sharing: Not stated. Countries: 24. Publications: 15.
Safety and Tolerability of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT01497262. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Lipoic Acid for Progressive Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT03161028. IPD Sharing: NO. Countries: 2. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.